Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCirata Regulatory News (CRTA)

Share Price Information for Cirata (CRTA)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.00
Ask:
17.95
Spread: 0.95 (5.588%)
Market Cap: £22.12m
CRTA Live PriceLast checked at - London Stock Exchange

Intraday Cirata Share Chart

Board Appointments

1 Oct 2024 07:00

RNS Number : 3208G
Cirata PLC
01 October 2024
 

1 October 2024

 

Cirata plc

("Cirata" or the "Company")

Board Appointments

 

 

Cirata (LSE: CRTA), is pleased to announce that Amanda Jobbins and Eric Collins have been appointed as NonExecutive Directors with immediate effect.

 

Mr Peter Lees, Senior Independent Director (SID) who joined the board 9 August 2022, and chairs the Nomination Committee, will resign from his position effective 31 December 2024.

 

Amanda brings with her a wealth of international experience, having served as Global Chief Marketing Officer for major SaaS and IT enterprise software companies in the USA, Europe and Asia. Amanda currently serves as Global Chief Marketing Officer for Vodafone Business and Director of GTM & Strategic Partners. Prior to this, she was Global Chief Marketing Officer at Infor as well as Chief Marketing Officer and Senior Vice President of Global Business Development at Oracle.

 

Eric is a seasoned entrepreneur and business builder in addition to being the co-founder of Impact X Capital Partners: a venture capital firm founded to back underrepresented entrepreneurs across Europe and the USA, in sectors such as technology, healthcare, education and media.

 

Eric served as Chief Operating Officer of Digital Surgery, acquired by Medtronic in 2020, which is a global leader in healthcare technology. Prior to this, Eric served as Chief Revenue and Distribution Officer at SwiftKey, a virtual keyboard app that was acquired by Microsoft in 2016, where he was responsible for driving both user and revenue growth.

 

Ken Lever, Chair, commented:

 

"Amanda and Eric bring broad business experience across a range of sectors to our board. Amanda has an excellent track record across major enterprise software businesses that will help Cirata capitalise on its potential through investment in sales, marketing and products. Eric's business acumen and proven ability as a revenue builder and value creator will be invaluable as we look to deliver on our growth strategy and meet our medium-term ambitions. We are delighted to have both on board.

 

During this period of major change and transition for Cirata Peter Lees' guidance and advice has been invaluable. The board extends its sincere thanks for the contribution Peter has made and wishes him well for the future."

 

Regulatory disclosure The following disclosures are made in accordance with Schedule 2(g) of the AIM Rules for Companies:

 

 

 

Amanda Catherine St Levans Jobbins, aged 56, holds no ordinary shares or options in the Company. Amanda's current and previous directorships are as follows:

 

 

Current Directorships/Partnerships

Previous Directorships/Partnerships (last 5 years)

The Cabin Gym Limited

Dowding Levans Capital Limited

Dabco Limited

Cable & Wireless Trade Mark Management Limited

Hang Technologies Limited

 

 

 

Eric Davis Collins, aged 58, holds no ordinary shares or options in the Company. Eric's current and previous directorships are as follows:

 

 

Current Directorships/Partnerships

Previous Directorships/Partnerships (last 5 years)

Impact X Capital Partners LLP

Impact X Launch LLP

IXC I (Scotland) Ltd

IXC I (England) Ltd

IXC I FP LP

Impact X Operations LLP

Impact X Studios Limited

The Foundation for Social Entrepreneurs

Autograph ABP

Looted LLP

 

Tech Nation Group Limited

 

 

 

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

 

 

For further information, please contact: 

 

Cirata

+1 (925) 380 1728

Stephen Kelly, Chief Executive Officer

Ijoma Maluza, Chief Financial Officer

Daniel Hayes, Investor Relations

FTI Consulting

+44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali

Stifel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Ben Good / Sarah Wong

Panmure Liberum (Joint Broker)

+44 (0)20 3100 2000

Max Jones / John More

 

 

About Cirata

 

Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKNEDEKLEFA
Date   Source Headline
1st Jun 20267:00 amRNSBlock Listing Return
20th May 20267:00 amRNSResult of AGM
5th May 20267:00 amRNSHolding(s) in Company
23rd Apr 20268:52 amRNSAmendment to Notice of Annual General Meeting
21st Apr 20267:00 amRNSGrant of Awards & PDMR Dealing
14th Apr 20267:00 amRNSTrading Statement
31st Mar 20263:39 pmRNSManagement Changes
31st Mar 20267:00 amRNSPreliminary Results
4th Feb 20268:54 amRNSGrant of Awards & PDMR Dealing
14th Jan 20267:00 amRNSQ4 FY25 Trading Update
19th Dec 20252:50 pmRNSDevOps Final Consideration Received
19th Dec 20252:50 pmRNSDevOps Final Consideration Received
1st Dec 20259:35 amRNSBlock Listing Return
27th Nov 20257:00 amRNSFinancial Conduct Authority Update
17th Nov 20257:00 amRNS$6.7m Multiyear Contract win
27th Oct 202510:05 amRNSNotification of Major Holdings
16th Oct 20257:00 amRNSTrading Statement
13th Oct 20257:00 amRNS$3.1m Multiyear Contract with leading US Insurer
12th Sep 202511:02 amRNSGrant of Awards & PDMR Dealing
10th Sep 20257:00 amRNSNotification of Major Holdings
9th Sep 20258:00 amRNS-RCirata launches new data platform
3rd Sep 20257:00 amRNSInterim results
13th Aug 20257:00 amRNSGrant of Share Options to PDMRs
11th Aug 20257:00 amRNSCompletion of DevOps Divestment
15th Jul 20257:07 amRNSQ2 and H1FY25 Trading Update
30th Jun 20257:01 amRNSHolding(s) in Company
30th Jun 20257:00 amRNS$700K Multiyear Data Integration Contract Renewal
10th Jun 20257:00 amRNSBoard Appointment
3rd Jun 20252:39 pmRNSBlock Listing Return
8th May 20254:47 pmRNSResult of AGM
29th Apr 202511:44 amRNSGrant of Share Options to PDMRs
16th Apr 20257:00 amRNSQ1FY25 Trading Statement
8th Apr 20257:00 amRNSAnnual Report & Notice of AGM
2nd Apr 20253:51 pmRNSNotification of Major Holdings
31st Mar 20257:01 amRNSContract win
31st Mar 20257:00 amRNSPreliminary Results
27th Feb 20257:00 amRNSNew logo in Telecom sector
20th Feb 20257:00 amRNSTotal Voting Rights
20th Jan 20256:29 pmRNSPDMR dealings and Total Voting Rights
9th Jan 20257:00 amRNSQ4FY24 Trading Update
16th Dec 20247:00 amRNSContract Win and FY24 Guidance
13th Dec 20243:46 pmRNSVesting of Restricted Stock & Director Dealings
11th Dec 20247:00 amRNSIssue of Equity
9th Dec 20247:00 amRNSMarvell Contract Renewal
2nd Dec 20243:40 pmRNSBlock Listing Return
1st Nov 20247:00 amRNSGrant of Share Options to PDMRs
24th Oct 20247:00 amRNSPDMR Transactions
9th Oct 20247:00 amRNSQ3 Trading Update and Outlook
2nd Oct 20243:19 pmRNSAmendment of OEM sales partnership with IBM
1st Oct 20247:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.